Preparation of Mycobacterium tuberculosis EsxV lipid nanoparticles subunit vaccine and its immunological characteristics
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    To prepare a lipid nanoparticle (LNP)-based subunit vaccine of Mycobacterium tuberculosis (Mtb) antigen EsxV and study its immunological characteristics, the LNP containing EsxV and c-di-AMP (EsxV:C:L) was prepared by thin film dispersion method, and its encapsulation rate, LNP morphology, particle size, surface charge and polyphase dispersion index were measured. BALB/c mice were immunized with EsxV:C:L by nasal drops. The levels of serum and mucosal antibodies, transcription and secretion of cytokines in lung and spleen, and the proportion of T cell subsets were detected after immunization. EsxV:C:L LNPs were obtained with uniform size and they were spherical and negatively charged. Compared with EsxV:C immunization, EsxV:C:L mucosal inoculation induced increased sIgA level in respiratory tract mucosa. Levels of IL-2 secreted from spleen and ratios of memory T cells and tissue-resident T cells in mice were also elevated. In conclusion, EsxV:C:L could induce stronger mucosal immunity and memory T cell immune responses, which may provide better protection against Mtb infection.

    Reference
    Related
    Cited by
Get Citation

白鹭,路延之,宁唤唤,康亚莉,谢燕玲,康健,李雪,崔若囡,韦垠,刘月芹,柏银兰. 结核分枝杆菌EsxV脂质体纳米颗粒亚单位疫苗的制备及免疫学特性[J]. Chinese Journal of Biotechnology, 2023, 39(10): 4085-4097

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:April 03,2023
  • Revised:
  • Adopted:June 28,2023
  • Online: October 17,2023
  • Published: October 25,2023
Article QR Code